导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -1.60% | 619/1050 |
| 近一周 | -3.11% | 933/1104 |
| 近一月 | -6.42% | 906/1103 |
| 近一季 | -6.56% | 543/1092 |
| 近半年 | -6.60% | 676/1070 |
| 近一年 | -15.50% | 822/1018 |
| 近两年 | 36.70% | 624/926 |
| 近三年 | 8.56% | 607/834 |
| 成立以来 | -33.13% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-2.01% 647/1070 |
14.38% 460/1101 |
- - |
- - |
| 2025 | 19.94% 672/1065 |
11.86% 104/1014 |
8.50% 144/1038 |
20.54% 591/1050 |
-18.02% 1023/1065 |
| 2024 | 3.25% 493/1011 |
-5.06% 568/960 |
-1.64% 417/983 |
20.33% 59/991 |
-8.11% 828/1011 |
| 2023 | -18.45% 634/952 |
-1.62% 692/880 |
-6.15% 586/895 |
-6.22% 377/915 |
-5.82% 593/952 |
| 2022 | -25.57% 511/867 |
-22.62% 659/773 |
14.30% 139/806 |
-23.61% 792/845 |
10.15% 73/867 |
| 2021 | -18.59% 528/740 |
-2.96% 266/580 |
7.60% 416/659 |
-13.44% 583/704 |
-9.93% 657/740 |
| 2020 | - - |
- - |
- - |
- - |
5.23% 435/554 |
| 2019 | - - |
- - |
- - |
- - |
- - |
| 2018 | - - |
- - |
- - |
- - |
- - |
| 2017 | - - |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 广发港股通成长精选股票A VS. 东吴新产业精选股票A(580008) |